Advertisement
News
Advertisement

Shire HGT wins FDA OK for HAE drug

Thu, 08/25/2011 - 4:58pm
Mass High Tech: The Journal of New England Technology

Shire Human Genetic Therapies Inc. has won approval for Firazyr, a drug to treat a rare condition called hereditary angioedema (HAE), according to a release from the FDA.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading